CoChat

Promise and pitfalls of quantitative imaging in oncology clinical trials

Open access
Kurland, Brenda F., Gerstner, Elizabeth R., Mountz, James M., Schwartz, Lawrence H., Ryan, Christopher W., Graham, Michael M., Buatti, John M., Fennessy, Fiona M., Eikman, Edward A., Kumar, Virendra, Forster, Kenneth M., Wahl, Richard L., Lieberman, Frank S. · 2012 · Magnetic Resonance Imaging
Cited by 104

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Quantitative imaging using CT, MRI, and PET modalities will play an increasingly important role in the design of oncology trials addressing molecularly targeted, personalized therapies. The advent of molecularly targeted therapies, exemplified by antiangiogenic drugs, creates new complexities in the assessment of response. The Quantitative Imaging Network (QIN) addresses the need for imaging modalities which can accurately and reproducibly measure not just change in tumor size, but changes in relevant metabolic parameters, modulation of relevant signaling pathways, drug delivery to tumor, and differentiation of apoptotic cell death from other changes in tumor volume. This article provides an overview of the applications of quantitative imaging to phase 0 through phase 3 oncology trials. We describe the use of a range of quantitative imaging modalities in specific tumor types including malignant gliomas, lung cancer, head and neck cancer, lymphoma, breast cancer, prostate cancer, and sarcoma. In the concluding section, we discuss potential constraints on clinical trials using quantitative imaging, including complexity of trial conduct, impact on subject recruitment, incremental costs, and institutional barriers. Strategies for overcoming these constraints are presented.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mri.2012.06.009

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 104

Metadata

Authors
Kurland, B. F., Gerstner, E. R., Mountz, J. M., Schwartz, L. H., Ryan, C. W., Graham, M. M., Buatti, J. M., Fennessy, F. M., Eikman, E. A., Kumar, V., Forster, K. M., Wahl, R. L., & Lieberman, F. S.
Venue
Magnetic Resonance Imaging
Publisher
Elsevier BV
Published
2012-11
Volume
30
Issue
9
Pages
1301-1312
ISSN
0730-725X (ISSN-L)
OpenAlex
W1971933336
Cited by
104
References
6
FWCI
5.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Promise and pitfalls of quantitative imaging in oncology clinical trials. https://app.cochat.ai/papers/10.1016/j.mri.2012.06.009
The paper
Kurland, B. F., Gerstner, E. R., Mountz, J. M., Schwartz, L. H., Ryan, C. W., Graham, M. M., Buatti, J. M., Fennessy, F. M., Eikman, E. A., Kumar, V., Forster, K. M., Wahl, R. L., & Lieberman, F. S. (2012). Promise and pitfalls of quantitative imaging in oncology clinical trials. Magnetic Resonance Imaging. https://doi.org/10.1016/j.mri.2012.06.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.